This is a Validated Antibody Database (VAD) review about mouse Cxadr, based on 7 published articles (read how Labome selects the articles), using Cxadr antibody in all methods. It is aimed to help Labome visitors find the most suited Cxadr antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cxadr synonym: 2610206D03Rik; AU016810; AW553441; CAR; MCAR; MCVADR
EMD Millipore
mouse monoclonal (RmcB) |
| EMD Millipore Cxadr antibody (Millipore, RmcB) was used in flow cytometry on human samples . Cancer Gene Ther (2020) ncbi |
mouse monoclonal (RmcB) |
| In order to identify human cytomegalovirus genes within the US12 family containing novel natural killer cell evasion functions, EMD Millipore Cxadr antibody (Merck Millipore, 05-644) was used in flow cytometry on human samples at 1:500 (fig 10). elife (2017) ncbi |
mouse monoclonal (RmcB) |
| In order to show the feasibility of adenoviral retargeting of tumor cells using the GRP78-binding peptide, EMD Millipore Cxadr antibody (millipore, 05-644) was used in flow cytometry on human samples (tbl 3). Cancer Gene Ther (2016) ncbi |
mouse monoclonal (RmcB) |
| EMD Millipore Cxadr antibody (Upstate, RmcB) was used in blocking or activating experiments on human samples at 1:100. PLoS Pathog (2015) ncbi |
mouse monoclonal (RmcB) |
| EMD Millipore Cxadr antibody (Upstate Cell Signaling Solutions, RmcB) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
mouse monoclonal (RmcB) |
| EMD Millipore Cxadr antibody (Millipore, RmcB) was used in flow cytometry on human samples . J Gene Med (2013) ncbi |
mouse monoclonal (RmcB) |
| EMD Millipore Cxadr antibody (Upstate Biotechnologies, 05-644) was used in flow cytometry on human samples at 1:250. Cancer Gene Ther (2007) ncbi |
Articles Reviewed
- Kasman L, Lu P, Voelkel Johnson C. The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells. Cancer Gene Ther. 2007;14:327-34 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments